Seeing Is Believing

Currently out of the existing stock ratings of Robbie Marcus, 185 are a BUY (59.87%), 103 are a HOLD (33.33%), 21 are a SELL (6.8%).
Analyst Robbie Marcus, currently employed at JPMORGAN, carries an average stock price target met ratio of 60.15% that have a potential upside of 18.69% achieved within 153 days.
Robbie Marcus’s has documented 607 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on COO, The Cooper Companies Common Stock at 10-Sep-2026.
Analyst best performing recommendations are on RXST (RXSIGHT).
The best stock recommendation documented was for INGN (INOGEN) at 5/8/2019. The price target of $72 was fulfilled within 1 day with a profit of $4.21 (6.21%) receiving and performance score of 62.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$0.74
$0.52 (236.36%)
$1
3 years 1 months 27 days ago
(08-Aug-2023)
5/8 (62.5%)
$0.1 (15.63%)
61
Hold
$1.5
$1.28 (581.82%)
4 years 1 months 19 days ago
(16-Aug-2022)
1/2 (50%)
$0.05 (3.45%)
2
Buy
$1.5
$1.28 (581.82%)
4 years 3 months 11 days ago
(24-Jun-2022)
1/5 (20%)
$0.96 (177.78%)
27
Sell
$19
4 years 10 months 23 days ago
(12-Nov-2021)
0/2 (0%)
$3.71 (16.84%)
Hold
$23
$21.36 (1302.44%)
$30
5 years 6 months 16 days ago
(19-Mar-2021)
0/3 (0%)
$4.37 (22.18%)
Which stock is Robbie Marcus most bullish on?
Which stock is Robbie Marcus most reserved on?
What Year was the first public recommendation made by Robbie Marcus?